Labiotech.eu

News and Trends 8 Jun 2022

Synklino raises €29.8M to trial cytomegalovirus drug

Danish biotech Synklino has completed a Series A fundraising round that netted €29.8M ($31.8M). The company is developing drugs for the treatment of chronic viral infections, and the funding will be used for its drug candidate, SYN002, for the treatment of cytomegalovirus (CMV). This will involve both ex vivo and in vivo Phase 1 clinical […]

June 8, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 8 Jun 2022

United Therapeutics creates 3D printed lung scaffold

United Therapeutics Corporation said it has – in partnership with 3D Systems Corporation – produced the world’s most complex 3D-printed object, a human lung scaffold. The human lung scaffold was demonstrated at the LIFE ITSELF Conference, held recently in San Diego, Cal. Martine Rothblatt, United Therapeutics’ chairperson and CEO, and Chuck Hull, 3D Systems’ co-founder, […]

June 8, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 7 Jun 2022

Cancer vaccine biotech CimCure raises €5M

Dutch biotech company CimCure, which is focusing on the development of vaccine-based cancer immunotherapy, has raised more than €5M ($5.3M) in a financing seed round led by Dutch company Positron Ventures. CimCure, a spin-off of the Amsterdam UMC medical center, is set to use the funds to advance its vaccine up to phase 1-2 clinical […]

June 7, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 7 Jun 2022

Yumanity selling neurology assets and merging with Kineta

U.S. biopharma company Yumanity Therapeutics, Inc. is selling off its lead clinical-stage neurodegenerative product candidate YTX-7739 to Janssen Pharmaceutica NV, and also entering a merger with Kineta, Inc. YTX-7739, as well as Yumanity’s discovery-stage neuroscience product candidates and targets are being sold to Janssen, part of the Janssen Pharmaceutical Companies of Johnson & Johnson, for […]

June 7, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 7 Jun 2022

Athersys to restructure – 70% of workforce to go

U.S. biotech company Athersys, Inc. has announced a corporate restructuring plan to reduce costs and prioritize its lead clinical programs. In connection with the restructuring, the company is reducing its workforce up to 70%, with most of the reduction expected to be completed by the end of June 2022. The company said this initial step […]

June 7, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 7 Jun 2022

ImmunOs Therapeutics raises $74M

ImmunOs Therapeutics AG, a biopharmaceutical company developing therapeutics for the treatment of cancer and autoimmune diseases, has announced the closing of an oversubscribed Series B financing round totaling $74M. The round was led by new investors Samsara BioCapital, Lightspeed Venture Partners, and Gimv, and joined by other new investors Mission BioCapital, GL Capital, PEAK6 Strategic […]

June 7, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 7 Jun 2022

Scotland’s industrial biotechnology sector to hit £1B turnover by 2025

Scotland’s industrial biotechnology community is exceeding growth expectations and is on track to achieve annual turnover of £1.2bn ($1.5B) by 2025. This is according to a renewed strategy launched at the Industrial Biotechnology Innovation Centre’s (IBioIC) annual conference this week. The updated National Plan for Industrial Biotechnology outlines new ambitions for Scotland’s bioeconomy, including reaching […]

June 7, 2022 - 3 minutesmins - By Jim Cornall

Gene therapy: can CDMOs solve the manufacturing bottleneck?

The gene therapy market is booming. Viral vectors, the key delivery systems for gene therapies, are playing an increasing role in the development of biologics. But the growing need for viral vectors and their plasmid building blocks have resulted in a manufacturing bottleneck. Can contract manufacturing organizations cope with the rising demand? In 2019, Zolgensma, a […]

June 7, 2022 - 7 minutesmins - By Ute Boronowsky

News and Trends 6 Jun 2022

Mitochondria in focus as 4BIO Capital co-leads $30.3M financing in LUCA Science

4BIO Capital, an international venture capital firm focusing on the advanced therapies sector, has co-led a $30.3M oversubscribed Series B financing in LUCA Science Inc., which is developing a novel class of mitochondria biopharmaceutical agents. The round was co-led with DCI Partners and existing investor Fast Track Initiative, and supported by existing international investors including […]

June 6, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 6 Jun 2022

Type 1 diabetes in the crosshairs with Imagine Pharma discovery

U.S. biotech company Imagine Pharma is showcasing its discovery of Type 1 Diabetes Activated Islet Progenitor Cells (T1D AIPCs) at the American Transplant Congress in Boston. The company said its industry breakthrough is a critical component for the potential treatment of T1D through autologous cell transplantation. T1D AIPCs are novel cell populations generated and propagated […]

June 6, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 6 Jun 2022

Report shows growth of life sciences sector in eastern Denmark

A new report on the Danish contribution to the Medicon Valley has been published. The report, Life Science in Eastern Denmark – The Danish Part of Medicon Valley is a survey of companies in the sector. Medicon Valley spans the Danish region of Zealand and the Capital Region, and the Skåne region of southern Sweden. […]

June 6, 2022 - 3 minutesmins - By Jim Cornall

In Depth 6 Jun 2022

Releasing the microbiome’s potential to restore European soils

For decades, soil has been treated as an everlasting food machine rather than as a fragile living thing, and it is reaching a crisis point. Understanding how the soil microbiome interacts with the environment and helping farmers embrace new sustainable methods can have a beneficial impact on the soil, and consequently, our health. After years […]

June 6, 2022 - 9 minutesmins - By Carlos de Rojas

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Synklino raises €29.8M to trial cytomegalovirus drug

United Therapeutics creates 3D printed lung scaffold

Cancer vaccine biotech CimCure raises €5M

Yumanity selling neurology assets and merging with Kineta

Athersys to restructure – 70% of workforce to go

ImmunOs Therapeutics raises $74M

Scotland’s industrial biotechnology sector to hit £1B turnover by 2025

Gene therapy: can CDMOs solve the manufacturing bottleneck?

Mitochondria in focus as 4BIO Capital co-leads $30.3M financing in LUCA Science

Type 1 diabetes in the crosshairs with Imagine Pharma discovery

Report shows growth of life sciences sector in eastern Denmark

Releasing the microbiome’s potential to restore European soils

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!